Pantoprazole in pharma franchise in Goa

Pantoprazole in PCD pharma franchise in Gangtok

Pantoprazole in top pharma company in Mumbai

Pantoprazole in pcd pharma supplier in Delhi

Pantoprazole in phama franchise company in India
Pantoprazole in phama distributor in Hyderabad

Home/Products /pantoprazole-80mg-dual-release-gastro-resistant-tablet

Panpital 80 Dr Tablet

Composition : Pantoprazole (80mg) Dual Release Gastro-Resistant

Dosage Form : Tablet

Packaging Type : Alu-Alu

Packaging : 10x15

Price : ₹271/-

Panpital 80 DR Tablet contains Pantoprazole (80mg) in a dual-release gastro-resistant formulation. Pantoprazole is a proton pump inhibitor (PPI) that works by reducing the production of stomach acid, providing relief from acid-related disorders. This advanced dual-release technology ensures sustained efficacy by maintaining therapeutic levels for an extended period, making it effective for managing acid-related conditions.

Pantoprazole is commonly prescribed for conditions such as gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, and peptic ulcers. It is particularly beneficial in cases where rapid and sustained acid suppression is necessary. Panpital 80 DR Tablet helps alleviate symptoms like heartburn, acid reflux, and indigestion while promoting healing of acid-related damage in the stomach and esophagus.

This formulation is optimized to ensure that the medication reaches the target site in the stomach without being degraded by stomach acid, maximizing its therapeutic potential. The dual-release mechanism enhances patient compliance by offering a once-daily dosing regimen, reducing the frequency of administration.

Read More

About the Product

Panpital 80 DR Tablet contains Pantoprazole (80mg) in a dual-release gastro-resistant formulation. Pantoprazole is a proton pump inhibitor (PPI) that works by reducing the production of stomach acid, providing relief from acid-related disorders. This advanced dual-release technology ensures sustained efficacy by maintaining therapeutic levels for an extended period, making it effective for managing acid-related conditions.

Pantoprazole is commonly prescribed for conditions such as gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, and peptic ulcers. It is particularly beneficial in cases where rapid and sustained acid suppression is necessary. Panpital 80 DR Tablet helps alleviate symptoms like heartburn, acid reflux, and indigestion while promoting healing of acid-related damage in the stomach and esophagus.

This formulation is optimized to ensure that the medication reaches the target site in the stomach without being degraded by stomach acid, maximizing its therapeutic potential. The dual-release mechanism enhances patient compliance by offering a once-daily dosing regimen, reducing the frequency of administration.

Possible side effects include headache, nausea, diarrhea, abdominal pain, or flatulence.

Panpital 80 DR Tablet is indicated for GERD, peptic ulcers, Zollinger-Ellison syndrome, and other conditions requiring prolonged acid suppression.

Take as directed by your healthcare provider. Do not crush or chew the tablet, and complete the full prescribed course.

Store below 25°C in a cool, dry place, away from direct sunlight and moisture.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation